This is due to the notable reductions in GH and IGF-1 after tumor debulking, whether the tumor is totally or partially resected, and will cause decreased IR and elevated insulin sensitivity, thus gradually easing the IR-induced β-cell hyperfunction (7, 39). The gene discussed is GH1; the disease is neoplasm.